Introduction
In 1990, the Lewy body variant of Alzheimer's disease (AD) [1] , also termed senile dementia of Lewy body type [2] or dementia with Lewy bodies (DLB) [3] , was described as a distinct neuropathological and clinical form of dementia in the elderly. Autopsy studies have shown that in 15-25% of elderly patients with dementia, Lewy bodies (LBs) are found in the cortex and brainstem in addition to various degrees of Alzheimer-type pathology. According to these studies, DLB may be the second most common cause of dementia after AD [1, 2, [4] [5] [6] .
As noted in the initial descriptions of the condition, patients with DLB share many clinical features with typical AD including age, family history, history of onset, symptoms, duration of disease, mental status and degree of brain atrophy [7] . Symptoms that distinguish DLB from AD without Lewy body pathology are disproportional impairment of attention, executive function and visuospatial performance as well as mild extrapyramidal fi ndings [1] . In studies on patients who met clinical and pathological criteria for AD, however, no consistent association has been found between the presence of LBs and the frequency of these clinical features [3] .
In addition to progressive dementia, the clinical consensus criteria [7] emphasize fl uctuation of attention and alertness, recurrent visual hallucinations and spontane-ous motor features of Parkinsonism. Impairment of memory may be absent at early stages. Using these criteria, the sensitivity of the clinical diagnosis is 78%, and the specifi city is 64% as compared with neuropathological fi ndings [8] . This is consistent with the fi nding that two thirds of patients with pathologically confi rmed DLB have less than two core clinical features [8] .
Here, we report on a small group of patients who fulfi lled clinical criteria for AD [9] but were identifi ed as having DLB at postmortem examination. The study was designed to determine whether classifi cation of DLB as AD might have been avoided if distinguishing features had been observed, or whether there is a variant of DLB that cannot be separated from AD on clinical grounds.
Methods

Patients
From 1988 to 1992, we conducted a prospective study which was designed to investigate the natural course and possible subtypes of AD [10] . A total of 90 patients were enrolled and re-examined at 12-month intervals for up to 3 years. All patients underwent a thorough diagnostic evaluation, which included psychiatric interview, physical examination, laboratory screening, cranial computed tomography and apolipoprotein E genotyping [11] .
Clinical Assessments and Diagnosis
The clinical documentation included information on age, age at onset, years of education at school and family history of dementia. Impairment of cognitive function was assessed using the cognitive section (CAMCOG) of the Cambridge Mental Disorders of the Elderly Examination (CAMDEX) [12] , which incorporates the MiniMental State Examination (MMSE). Out of 8 subscales of this standardized interview, 5 were considered in the present study (orientation, language, memory, praxis and perception). The CAMDEX protocol also provides information on activities of daily living (ADL) obtained from an informant (orientation in and around the home, performing household chores, handling money, eating, dressing, bladder and bowel control). For the present analysis, these variables were combined into an ADL score, higher values indicated greater impairment. Furthermore, informant ratings of noncognitive symptoms were taken from the CAMDEX standardized interview (hallucinations, paranoid ideation and fl uctuating attention). These symptoms were rated as present or absent.
Neurological signs were documented in a standardized form. Of 10 signs recorded, gait disorder and increased muscle tone were selected and combined in a neurological score for the present analysis. Tremor was recorded as part of the CAMDEX documentation. Severity of dementia was rated on the Dementia Scale (DS) [13] , the Global Deterioration Scale (GDS) [14] and the Clinical Dementia Rating (CDR) [15] .
Based on this extensive information, a consensus diagnosis of AD was made by two experienced clinicians according to ICD-10 research criteria [9] . A probable AD was diagnosed using the NINCDS-ADRDA criteria [16] . In 1996, Rasmussen et al. [17] showed that these diagnoses are 90% accurate. At the time of study, diagnostic criteria for DLB were not available, since they were only introduced in 1992 [18] . Patients who had marked neurological symptoms or a history of cerebrovascular accidents were not included.
Neuropathological Evaluation and Diagnostic Criteria
Brains were fi xed in 4% formalin in phosphate-buffered saline for at least 14 days. Representative blocks were embedded in paraffi n and processed for routine histology. Sections (4 m) were cut and stained with hematoxylin and eosin, according to Gallyas and Bielschowsky silver impregnation. Immunohistochemistry was performed with anti-tau antibody AT8 (dilution 1: 100; Innogenetics, Ghent, Belgium), anti-synuclein antibody 15G7 (dilution 1: 10), anti-␤ amyloid peptide antibody (1: 100; Dako, Glostrup, Denmark) and anti-ubiquitin antiserum (1: 300; Dako). Antibody binding was detected using the Dako alkaline phosphatase/anti-alkaline phosphatase system and neufuchsin as chromogen.
The pathological diagnosis was made using established international criteria. Alzheimer's pathology was classifi ed using the CERAD pathologic criteria, based on semiquantitative analysis of neuritic plaques [19] , as well as the Braak and Braak classifi cation, based on the distribution of neurofi brillary tangles and neuropil threads [20] .
Distribution and frequency of LBs were evaluated according to consensus guidelines for diagnosing DLB [7] . The number of LBs was counted in the therein defi ned brain regions using ␣ -synuclein immunohistochemistry and was converted into scores of 0 (no LBs), 1 (1-4 LBs) and 2 ( 1 5 LBs) for each area. Based on the total score, cases were divided into 3 subtypes: brainstem predominant, limbic and neocortical.
The neuropathological diagnosis of DLB was made if LBs were present in the diagnostic areas, irrespective of the severity of AD pathology.
The diagnosis of dementia lacking distinctive histopathology (DLDH) and corticobasal degeneration (CBD) was made according to McKhann et al. [21] and Dickson et al. [22] , respectively.
Postmortem diagnosis was attempted in as many patients as possible. Of the 66 patients who had died between 1988 and 1997, autopsy was obtained in 27 cases. The clinical diagnosis of AD was confi rmed in 19 patients, 6 patients had additional Lewy body pathology and were classifi ed as DLB. Two patients showed no ADrelated pathology and were diagnosed as DLDH or CBD. Neuropathological information is shown in table 1 .
Apolipoprotein E Genotyping
The apolipoprotein E genotype was determined according to the procedures described previously [23] .
Data Analysis
Statistical analysis was performed using the Statistical Package for the Social Sciences [24] , version 10.0. Demographic data, severity ratings (MMSE, DS, GDS, CDR), CAMCOG subscores, ADL, BEH and neurological scores were compared between AD and DLB patients applying
Results
Demographic Data
Patients with AD and DLB did not differ signifi cantly regarding gender distribution and years of education. However, DLB patients were signifi cantly older than AD patients ( table 2 ) . A family history of dementia was found in 26% in AD and 33% in DLB cases ( table 3 ) .
Apolipoprotein E Genotype
Of the 19 patients with AD, 14 were carriers of the apolipoprotein E 4 allele, whereas only 3 of 6 patients with DLB were 4 positive. The 4 allele frequency was 0.42 in the AD group and 0.50 in the DLB group. This difference was not statistically signifi cant (p = 0.12) ( table 3 ) .
Cranial Computed Tomography
Brain atrophy was seen in 13 out of 17 patients with AD (76%) for whom CT scans were available and in 5 patients with DLB (83%). This difference did not reach statistical signifi cance ( table 3 ) .
Severity of Dementia
Although they were signifi cantly older, patients with DLB achieved a higher cognitive performance on the MMSE than patients with AD ( table 4 ). Due to the small sample size, the difference of 4 points on the scale was not of statistical signifi cance. General severity of dementia, as assessed using the DS, GDS or CDR, was not different between the two diagnostic groups.
Cognitive Ability
There was no statistically signifi cant difference on any CAMCOG subscale between the two diagnostic groups ( table 4 ). Fluctuation of attention was not observed in either group.
Noncognitive Symptoms
Hallucinations were present in 2 out of 6 patients with DLB and in 1 out of 19 patients with AD. This difference fell short of reaching statistical signifi cance ( table 4 ) .
ADL and Neurological Symptoms
There were no statistically signifi cant differences between the diagnostic groups with regard to these symptoms ( table 5 ) . Furthermore, tremor was absent in both groups. 
Discussion
The present study refers to a highly selected group of patients who were referred to a university memory clinic for diagnostic evaluation. All patients included in this study fulfi lled ICD-10 research criteria for AD [9] . At postmortem examination, AD was confi rmed in 19 of these patients, but 6 subjects were found to have DLB. All cases classifi ed as DLB had severe Alzheimer-related pathology (CERAD C and Braak and Braak stage V-VI) in addition to signifi cant Lewy body counts in diagnostically important areas. In the present paper, we compare cognitive, noncognitive and neurological symptoms between the two groups at the time of enrollment. The objective of the study was to identify clinical features that distinguish patients with DLB who were classifi ed as AD from patients with AD.
Patients with DLB were signifi cantly older at onset of symptoms than AD patients. On ratings of dementia severity, the two groups were identical, the majority of patients showing a moderate degree of intellectual impairment. Furthermore, there was no difference in the ability to carry out ADL. On the MMSE, however, patients with DLB had higher average scores than patients with AD, suggesting that their cognitive performance was better. This is consistent with a nonsignifi cantly higher score on the memory subtest of the CAMCOG. There was no difference between the groups in any other cognitive domain. This indicates that the profi le of cognitive abilities may not be useful for the differentiation between AD and DLB.
Even though present clinical diagnostic criteria for DLB were not available at the time of our study, we feel confi dent that the clinical assessment covered all the important early signs of DLB. Typical symptoms, such as fl uctuating attention, visual hallucinations and tremor, are part of the CAMDEX interview, and neurological symptoms with focus on additional features of Parkinsonism were recorded in a standardized form. Parkinsonian symptoms, in particular tremor, gait disorder and increased muscle tone, were absent in both groups. Another major feature of DLB [7] was absent in the DLB group, namely fl uctuating attention. Furthermore, hallucinations were only present in one third of these individuals. There have been previous comparisons between AD and DLB in patients with neuropathologically confi rmed diagnosis, which also did not fi nd any differences regarding cognitive impairment, hallucinations and fl uctuating attention [25] . A recent study comes to the similar conclusion that patients with signifi cant tangle pathology who are pathologically assigned a DLB diagnosis were clinically indistinguishable from AD [26] . On the other hand, there are authors who report that visual hallucinations are more common in DLB [27, 28] and suggest that the distinction between AD and DLB may be improved by greater emphasis on hallucinations [29] . Furthermore, some studies found a signifi cantly higher impairment of attention in patients with DLB [30] and more fl uctuations of attention compared with patients who suffered from AD [31, 32] . Fluctuating attention also has a signifi cant impact on ADL [33] .
Genetic risk factors also did not discriminate between the groups; approximately one third of the DLB and AD patients had a positive family history of dementia, and the apolipoprotein E 4 allele frequency was elevated above control values to a similar extent in both groups. This fi nding is consistent with several other studies which also found no difference in the 4 allele frequency between AD and DLB [34] [35] [36] . In addition, the frequency of atrophic changes seen on CT scans was not different between the two groups. Previous studies have found a strong correlation between DLB and occipital defi cits in cerebral perfusion [37] and glucose metabolism [38, 39] . However, as was the case in the present study, no changes in occipital brain structure were seen [40] and the CT or MRI fi ndings did not differ between the two types of dementia [41] . Taken together, our fi ndings suggest that Lewy body pathology may be present in patients who do not show any of the clinical features which distinguish DLB from AD according to present diagnostic criteria. This is consistent with the sensitivity of these criteria of 78%, which has been found in clinicopathological correlations [8] . Diagnostic sensitivity may possibly be improved by including more sensitive tests of attention and executive ability in the neuropsychological evaluation and by using the full range of diagnostic possibilities, such as positron emission tomography [39, 42, 43 ] , brain perfusion scintigraphy [44] and liquor markers [45] [46] [47] .
